Indications and uses
relieves and helps prevent recurrence of psoriasis symptoms including: scaling flaking itching redness irritation
relieves and helps prevent recurrence of psoriasis symptoms including: scaling flaking itching redness irritation
apply to affected areas once daily or as directed by a doctor use in conjunction with the Prosoria Daily Psoriasis Treatment System.
store at room temperature 59-77°F (15-25°C).
Drug Facts
Salicylic acid, 3%
Antipsoriasis
relieves and helps prevent recurrence of psoriasis symptoms including:
For external use only
When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.
Stop use and consult a doctor if the condition worsens or does not improve after regular use of this product as directed and/or if condition covers a large area of the body.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Citric Acid, Curcuma Longa (Turmeric) Root Extract, Cyclodextrin, Disodium EDTA, Ethoxydiglycol, Polyacrylate Crosspolymer-6, Potassium Sorbate, Oleth-3 Phosphate, Sodium Hydroxide, Tetrahydrodiferuloylmethane, Water.
Visit
www.prosoria.com or call toll-free 1-833-776-7483 Mon - Fri, 8am - 5pm CT.
Distributed by Nuvothera, Inc.
Fort Worth, TX 76104
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71573-102-01 | Prosoria Psoriasis Treatment | 59 mL in 1 BOTTLE, PLASTIC | GEL | 59 | 6 | |
| 71573-102-08 | Prosoria Psoriasis Treatment | 118 mL in 1 BOTTLE, PLASTIC | GEL | 118 | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71573-102 | 71573-102-01, 71573-102-08 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Prosoria Psoriasis Treatment | SALICYLIC ACID | Nuvothera, Inc. | 378311aa-95f7-4c69-bc00-e688468262bd | 2026-08-18 | Warnings | 71573-102-01 71573010201 |
| Prosoria Psoriasis Treatment | SALICYLIC ACID | Nuvothera, Inc. | f94f4481-c58e-4555-9863-cbaa2c4cdd07 | 2024-01-10 | Warnings | 71573-102-01 71573-102-08 71573-102 71573010208 71573010201 cdff94ae-4a19-40d1-9e9f-8caa42577394 f94f4481-c58e-4555-9863-cbaa2c4cdd07 |
Adverse event summaries are temporarily unavailable. Other product information remains available.